Compounded tirzepatide in Dallas: how the program works at Privé Aesthetics

Compounded tirzepatide at Privé Aesthetics is a GLP-1 and GIP receptor agonist prescribed as part of a medically supervised weight-loss program in Highland Park, Dallas — compounded at a U.S. licensed, FDA-registered pharmacy, prescribed under physician supervision by Medical Director Dr. Gregory Gardner, DO, with lab work and monthly check-ins included. It is not a quick fix; it is a structured monthly program.

The compounded GLP-1 conversation is the fastest-growing one in our consultation room. It is also one of the most poorly served by current marketing. Most of what patients have read is either over-promising (specific weight-loss outcomes guaranteed) or under-explaining (no clear picture of what the monthly program actually looks like). This piece is the explanation we wish was easier to find — what compounded tirzepatide is, how Privé structures the program, what the cadence looks like month-by-month, and what we are honest about up front.

What "compounded" actually means

Tirzepatide is a peptide molecule that activates two receptor systems involved in appetite, gastric emptying, and glucose regulation. The molecule exists in two forms relevant to patient care: as finished pharmaceutical drug products manufactured by branded pharmaceutical companies, and as a compounded preparation formulated at a U.S. licensed, FDA-registered compounding pharmacy under physician prescription.

The compounded version is what Privé prescribes. It is not the same product as the branded finished drug. It is not FDA-approved as a finished drug product; it is a pharmacy-compounded formulation made for the individual patient under prescription, in accordance with applicable state and federal compounding regulations. The pharmacy we work with is licensed in the United States, FDA-registered, and operates under the standards required for sterile compounding.

We do not compare compounded tirzepatide to branded finished drug products by name, and we do not claim equivalence in marketing. What we do is provide medically supervised access to a compounded preparation under physician prescription — the same regulatory pathway used by many compounding pharmacies and physician practices in the United States.

How the program is structured

The Privé compounded weight-loss program is organized as a monthly subscription with three structural phases.

Phase 1 — consultation, lab work, and titration start (Month 1). The first appointment is a comprehensive consultation with the clinical team. Medical history, current medications, goals, and contraindication screening. Baseline lab work is drawn — complete metabolic panel, lipid panel, A1C, thyroid function, and any additional tests indicated by individual history. Lab work is included in the first-month program fee. Based on the consultation and labs, Dr. Gardner writes the initial prescription; the pharmacy compounds and ships; titration begins at the lowest dose.

Phase 2 — titration through tolerance (Months 2-4 typical). Dose adjustments happen at the pace your body tolerates. Most patients move up through the dose tiers during this phase. Monthly check-ins assess response, side effects, and biometric trends. If side effects are intolerable at a given dose, we hold or step down rather than push through.

Phase 3 — maintenance + monitoring (Months 5 onward). Once the right dose is established, the program continues with monthly prescriptions and check-ins for ongoing monitoring. Lab work is repeated periodically depending on clinical indication. Duration of the program varies by patient goal — some are 6 to 12 month protocols; others continue longer for maintenance.

How tirzepatide works

Tirzepatide is a dual incretin-receptor agonist — it activates both the GLP-1 receptor (glucagon-like peptide-1) and the GIP receptor (glucose-dependent insulinotropic polypeptide). These are two of the body's natural appetite and glucose-regulating signaling pathways.

Mechanistically, tirzepatide slows gastric emptying (food stays in the stomach longer, producing extended satiety), reduces post-meal glucose spikes, and signals appetite-regulation centers in the brain to reduce hunger between meals. The dual GLP-1 + GIP activation distinguishes it from molecules that activate only the GLP-1 receptor. Whether that dual mechanism is meaningfully better for any given patient is an individual question we work through clinically.

Compounded tirzepatide vs compounded semaglutide

Privé carries both. Compounded semaglutide activates the GLP-1 receptor only. Compounded tirzepatide activates GLP-1 and GIP. Practical differences include cost (semaglutide programs start at $350/month; tirzepatide programs start at $500/month), individual response variability, and side-effect profile. Some patients respond better to one than the other. The decision is made at consultation, sometimes after a trial of one or the other.

What to expect — realistic framing

Results vary by individual. Some patients see meaningful weight change in the first 60-90 days; others take longer. Lifestyle factors — diet quality, exercise, sleep, stress, and especially protein intake during weight loss — substantially influence outcomes. We are upfront about this at consultation. We do not promise specific weight loss numbers in our marketing because the responsible clinical answer is that the right number depends on the patient.

The most common side effect is nausea, particularly during dose titration. It is usually transient. Reduced appetite is the intended mechanism but can sometimes tip into unwanted appetite suppression — we monitor for this. Gastrointestinal effects (constipation or loose stools) are also common during titration. Rare but serious risks include pancreatitis and gallbladder events; contraindications include a personal or family history of medullary thyroid cancer, multiple endocrine neoplasia syndrome type 2, history of pancreatitis, pregnancy, and breastfeeding. The monthly check-in cadence is partly about catching these early.

Cost transparency

Compounded weight-loss pricing at Privé is published openly: compounded tirzepatide starts at $500/month; compounded semaglutide starts at $350/month. The first month includes consultation and baseline labs. Final pricing depends on dose titration and program duration; we confirm at consultation. Financing options (Cherry, CareCredit) are accepted.

Most clinics do not publish weight-loss program pricing. We do, because patients comparison-shopping deserve to do that math without having to call. The pricing structure also reflects that this is a sustained monthly program, not a single-purchase product.

The regulatory landscape — what we tell patients honestly

Compounded GLP-1 medications operate in a regulatory landscape that has been evolving rapidly. The FDA has taken enforcement actions against medspas and providers making improper claims or operating outside compounding regulations. We take this seriously. Our approach is to follow applicable state and federal compounding regulations strictly: we prescribe through physician oversight (Dr. Gardner, DO, as Medical Director), our pharmacy is U.S. licensed and FDA-registered, and we do not make outcome claims, brand-equivalence claims, or FDA-approval claims for the compounded product.

Patients who want a branded finished drug product instead of a compounded preparation should pursue that through their primary care physician or another route. The compounded program at Privé is for patients who want access to a compounded peptide preparation under physician supervision, with the structured monitoring program described above.

Who the program is right for

Medically appropriate adults seeking sustainable weight management who can commit to the monthly cadence and tolerate self-administered subcutaneous injection. Patients who want a structured, monitored program rather than ad-hoc treatment. Patients in their 30s through 60s who are pairing weight-loss work with broader wellness goals.

Not the right fit: patients seeking dramatic short-term results, patients with contraindications listed above, patients who would skip monthly check-ins, patients looking for a branded finished drug product rather than a compounded preparation, and patients pregnant or breastfeeding.

How this fits with other Privé services

Many patients on the weight-loss program layer in additional Privé services for the broader wellness picture: peptide therapy for energy, recovery, and longevity protocols; IM and IV vitamin therapy for the nutritional support that matters during weight loss; truSculpt body contouring for the cosmetic finishing work some patients want after sustained weight loss; and our Luxe Skin Club membership for the skin maintenance that becomes more relevant as weight loss progresses. The program is built to integrate, not to be siloed.